Join Vimta’s bioanalytical and regulatory scientists at CPhI India for a three-day deep-dive into next-gen impurity testing, method validation under revised CDSCO guidelines, and practical strategies for accelerating ANDA filings in 2026.
Featured Service
Fast, Reliable Gene‑to‑Clinic Development
Bring your biologic program to life with an end‑to‑end CRADS platform
View service